In the region between the North Sea, Baltic Sea and Elbe River, one of the most important locations for medical technology, pharmaceuticals and biotechnology has developed in recent decades. (…) Life Science Nord has established itself as one of the leading life science networks in Europe. Some 500 companies, research institutes and institutions with 52,800 employees, a gross value added of EUR 5.0 billion and an export volume of EUR 6.6 billion are based in the region*. https://lifesciencenord.de/de/standort/wissenswertes.html

The head of ILAG, Dr. Michael Bau, is a member of the LSN working group on organisational development. While heading the working group in 2019 and 2020 he successfully supported the thematic direction and re-orientation of the working group.